Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost Ophthalmic Topical Cream low-dose

travoprost ophthalmic topical cream low-dose once daily in the evening to both eyes

DRUG

Travoprost Ophthalmic Topical Cream mid-dose

travoprost ophthalmic topical cream mid-dose once daily in the evening to both eyes

DRUG

Travoprost Ophthalmic Topical Cream high-dose

travoprost ophthalmic topical cream high-dose once daily in the evening to both eyes

DRUG

Timolol maleate ophthalmic solution, 0.5%

timolol maleate ophthalmic solution, 0.5% twice daily (morning \& evening) to both eyes

DRUG

Travoprost Ophthalmic Solution, 0.004%

travoprost ophthalmic solution, 0.004% once daily in the evening to both eyes

Trial Locations (1)

92663

RECRUITING

Glaukos Clinical Study Site, Newport Beach

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY